AUCTORES
Globalize your Research
Research Article | DOI: https://doi.org/10.31579/2692-9406/009
*Corresponding Author: Robert Skopec, Researcher-analyst, Dubnik, Slovakia.
Citation: Robert Skopec. (2020) Coronavirus Is A Biological Warfare Weapon. Biomedical Research and Clinical Reviews. 1(2); DOI: 10.31579/2692-9406/009
Copyright: © 2020 Robert Skopec, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 08 June 2020 | Accepted: 22 July 2020 | Published: 27 July 2020
Keywords: coronavirus; biological warfare weapon; the world health organization; the biological weapons convention; the wuhan bsl-4 lab
Dr. Francis Boyle, who drafted the Biological Weapons Act has given a detailed statement admitting that the 2019 Wuhan Coronavirus is an offensive Biological Warfare Weapon and that the World Health Organization (WHO) already knows about it. Francis Boyle is a professor of international law at the University of Illinois College of Law. He drafted the U.S. domestic implementing legislation for the Biological Weapons Convention, known as the Biological Weapons Anti-Terrorism Act of 1989, that was approved unanimously by both Houses of the U.S. Congress and signed into law by President George H.W. Bush.
Dr. Boyle discusses the coronavirus outbreak in Wuhan, China and the Biosafety Level 4 laboratory (BSL-4) from which he believes the infectious disease escaped. He believes the virus is potentially lethal and an offensive biological warfare weapon or dual-use biowarfare weapons agent genetically modified with gain of function properties, which is why the Chinese government originally tried to cover it up and is now taking drastic measures to contain it. [1, 2]
The Wuhan BSL-4 lab is also a specially designated World Health Organization (WHO) research lab and Dr. Boyle contends that the WHO knows full well what is occurring.
Dr. Boyle also touches upon GreatGameIndia‘s exclusive report Coronavirus Bioweapon – where we reported in detail how Chinese Biowarfare agents working at the Canadian lab in Winnipeg were involved in the smuggling of Coronavirus to Wuhan’s lab from where it is believed to have been leaked. [3, 4]
Dr. Boyle’s position is in stark contrast to the mainstream media’s narrative of the virus being originated from the seafood market, which is increasingly being questioned by many experts. [5, 6]
Recently, American Senator Tom Cotton of Arkansas also dismantled the mainstream media’s claim on Thursday that pinned the coronavirus outbreak on a market selling dead and live animals. [11, 12]
In a video accompanying his post, Cotton explained that the Wuhan wet market (which Cotton incorrectly referred to as a seafood market) has been shown by experts to not be the source of the deadly contagion.
Cotton referenced a Lancet study which showed that many of the first cases of the novel coronavirus, including patient zero, had no connection to the wet market — devastatingly undermining mainstream media’s claim. [7, 8]
“As one epidemiologist said: ‘That virus went into the seafood market before it came out of the seafood market.’ We still don’t know where it originated,” Cotton said.
“I would note that Wuhan also has China’s only bio-safety level four super laboratory that works with the world’s most deadly pathogens to include, yes, coronavirus.”
Such concerns have also been raised by J.R. Nyquist, the well known author of the books “Origins of the Fourth World War” and “The Fool and His Enemy,” as well as co-author of “The New Tactics of Global War”. In his insightful article he published secret speechs given to high-level Communist Party cadres by Chinese Defense Minister Gen. Chi Haotian explaining a long-range plan for ensuring a Chinese national renaissance – the catalyst for which would be China’s secret plan to weaponiz viruses. [9, 10]
Nyquist gave three different data points for making his case in analyzing Coronavirus. He writes:
The third data point worth considering: the journal GreatGameIndia has published a piece titled “Coronavirus Bioweapon – How China Stole Coronavirus From Canada And Weaponized It.”[11, 12]
The authors were clever enough to put Khan’s Virology Journal article together with news of a security breach by Chinese nationals at the Canadian (P4) National Microbiology Lab in Winnipeg, where the novel coronavirus was allegedly stored with other lethal organisms. Last May, the Royal Canadian Mounted Police were called in to investigate; by late July the Chinese were kicked out of the facility. The chief Chinese scientist (Dr. Xiangguo Qiu) was allegedly making trips between Winnipeg and Wuhan.
Here we have a plausible theory of the NCoV organism’s travels: first discovered in Saudi Arabia, then studied in Canada from whence it was stolen by a Chinese scientist and brought to Wuhan. Like the statement of Taiwan’s intelligence chief in 2008, the GreatGameIndia story has come under intensive attack. Whatever the truth, the fact of proximity and the unlikelihood of mutation must figure into our calculations.
It’s highly probable that the 2019-nCoV organism is a weaponized version of the NCoV discovered by Saudi doctors in 2012.
Meanwhile, the mainstream media’s narrative still maintains that the origin of the 2019 Coronavirus is the Wuhan Seafood Market. After GreatGameIndia published the story on Coronavirus Bioweapon – not only were our databse tinkered with and our reports blocked by Facebook on the flimsy reason that they could not find GreatGameIndia Facebook page, but the report itself was viciously attacked by Foreign Policy magazine, PolitiFact (known widely as Facebook’s propaganda arm) and BuzzFeedNews.
It is not GreatGameIndia alone which is being viciously attacked. Zero Hedge, a popular alternate media blog was suspended by Twitter for publishing a story related to a study by Indian scientists finding 2019 Wuhan Coronavirus to be not naturally evolved, raising the possibility of it being created in a lab. Shockingly, the study itself came under intense online criticism by Social Media experts resulting in the scientists withdrawing the paper.
In retaliation India has launched a full-scale investigation against China’s Wuhan Institute of Virology. [6, 7] The Indian government has ordered an inquiry into a study conducted in the Northeastern state of Nagaland (close to China) by researchers from the U.S., China and India on bats and humans carrying antibodies to deadly viruses like Ebola.
The study came under the scanner as two of the 12 researchers belonged to the Wuhan Institute of Virology’s Department of Emerging Infectious Diseases, and it was funded by the United States Department of Defense’s Defense Threat Reduction Agency (DTRA).
The study, conducted by scientists of the Tata Institute of Fundamental Research, the National Centre for Biological Sciences (NCBS), the Wuhan Institute of Virology, the Uniformed Services University of the Health Sciences in the U.S. and the Duke-National University in Singapore, is now being investigated for how the scientists were allowed to access live samples of bats and bat hunters (humans) without due permissions.
The results of the study were published in October last year in the PLOS Neglected Tropical Diseases journal, originally established by the Bill and Melinda Gates Foundation.
As the author J.R. Nyquist puts it:
We must have an investigation of the outbreak in Wuhan. The Chinese must grant the world total transparency. The truth must come out. If Chinese officials are innocent, they have nothing to hide. If they are guilty, they will refuse to cooperate.
The real concern here is whether the rest of the world has the courage to demand a real and thorough investigation. We need to be fearless in this demand and not allow “economic interests” to play a coy and dishonest game of denial. We need an honest inquiry. We need it now.
The corrupt establishment will do anything to suppress critical sites like the Burning Platform, etc., from revealing the truth. The corporate media does this by demonetizing sites like mine by blackballing the site from advertising revenue.
Trump threatens to halt WHO funding, review U.S. membership
U.S. President Donald Trump threatened on Monday to permanently halt funding for the World Health Organization (WHO) if it did not commit to improvements within 30 days, and to reconsider his country's membership of the agency. [13, 14]
Trump suspended U.S. contributions to the WHO last month, accusing it of promoting Chinese "disinformation" about the novel coronavirus outbreak, although WHO officials denied the accusation and China said it was transparent and open.
"If the WHO does not commit to major substantive improvements within the next 30 days, I will make my temporary freeze of United States funding to the WHO permanent and reconsider our membership," Trump told its chief, Tedros Adhanom Ghebreyesus, in a letter posted https://bit.ly/3bNB3R7 on Twitter.
Earlier, Trump said the Geneva-based WHO had "done a very sad job" in its handling of the coronavirus, which emerged in China late last year, and he would make a decision on funding soon.
Trump said in the letter the only way forward for the WHO was for it to demonstrate independence from China, adding that his administration had started discussing reform with Tedros.
Trump also made various accusations against China in the letter including that it tried to block evidence the virus could be transmitted between people, pressed the WHO not to declare it an emergency, refused to share data and samples and denied access to its scientists and facilities.
China hit back on Tuesday with its foreign ministry spokesman, Zhao Lijian, saying the letter was slanderous.
"The U.S. leadership’s open letter is filled with phrases of suggestions, maybes, and potentialities, and is trying to mislead the public through this specious method, to achieve the goal of smearing and slandering China’s efforts in epidemic prevention and to shift responsibility in its own incompetence in handling the epidemic," Zhao told a regular briefing.
Zhao said the U.S. decision to stop contributing to the WHO was a violation of its international obligations. (15, 16)
'REVIEW AS SOON AS POSSIBLE'
A WHO spokeswoman in Geneva said on Tuesday the agency had no immediate comment on Trump's letter but expected to have "more clarity" and a reaction to it later in the day.
On Monday, the WHO said an independent review of the global coronavirus response would begin as soon as possible and it had received backing and a hefty pledge of funds from China.
The WHO, a U.N. specialized agency, is leading a global initiative to develop safe and effective vaccines, tests and drugs to prevent, diagnose and treat COVID-19, the disease caused by the virus.
More than 4.75 million people have been infected globally and 314,414 have died, according to a Reuters tally.
The United States contributed more than $400 million to the WHO in 2019, or about 15% of its budget.
This year, the United States has already paid the WHO about $58 million, senior Trump administration officials said last month, half of what it is required to pay for 2020 - known as an assessed contribution.
The United States traditionally provides several hundred million dollars annually in voluntary funding tied to specific WHO programmes like polio eradication, vaccine-preventable disease, HIV and hepatitis, tuberculosis, and maternal and child and health. [15, 16]
It was not clear how much voluntary funding the United States has provided for WHO programmes in 2020.
(Reporting by Rama Venkat in Bengaluru and Huizhong Wu in Beijing; Editing by Clarence Fernandez, Robert Birsel)
Vladimir Putin Is in Deep Trouble
Russian President Vladimir Putin is suddenly seen to be weaker than he has been in years, and economic pain from COVID-19 is one big reason, but not the only one.
“Putin’s approval rating began to decline even before the coronavirus crisis, with oil prices collapsing and the economy deteriorating—and I don’t see what can stop this perfect storm this year,” says Denis Volkov, deputy director of the Levada Center, which does independent polling.(Meet Russia’s Dr. Oz, the COVID Skeptic Who Has Putin’s Ear)
“We see the public mood is changing the way we saw it during the crisis of 2008. (About 25 percent of our respondents say their salaries have been cut.),” Volkov told The Daily Beast. But Putin, like U.S. President Donald Trump, has die-hard fans, and “there is still a big group of people who say there is no alternative [to him].”
Putin’s biggest challenge is poverty, that old Russian disease. During his best years, when oil prices were astronomical and revenues were very high indeed, the Russian president was able to provide people with money—and with pride. He was building the armed forces, sending them abroad, overtly or covertly, to Ukraine, Syria, and Africa, and developing very expensive new weapons systems. Putin seemed able to provide, as economists say, both guns and butter. [17, 18]
But this year the nation’s rapidly shrinking economy has pushed millions below the poverty line, and Putin—whose approval rating was 80 percent in 2014, has seen his numbers, already in decline, drop precipitously. The current number of 59 percent would be positive in the West, but here in Russia, Putin has been used to nearly complete control over television news coverage, and he’s been losing that grip.
The Kremlin's major newspaper, Rossiyskaya Gazeta, claims that 70 percent of people still get their news from Kremlin controlled TV, but 58 percent follow news on the internet as well—or instead of—on state media.
So far, dozens of independent news websites have managed to keep functioning, covering news from all angles. But they are under threat, Kirill Kharatyan, editor of Vedomosti, one of Russia's few independent newspapers, told The Daily Beast. As the Putin government’s popularity declines, he said, concern grows “there will be more pressure on independent newspapers"
Where the economy is concerned, the government is quick to point out it has reserves for the state budget, and will meet public sector payrolls. But propping up the economy as a whole is another matter. Last year, even before the pandemic, the Federal State Statistics Service reported 20.9 million Russians, more than 14 percent of the population, living on less than $200 a month.
HUNGER PANGS
Smolensk lies about halfway between Moscow and Minsk, in Belarus. It is the poorest region in Russia’s central federal district, and it is in trouble these days.
Simply put, unemployed people cannot afford food. From the first weeks of the pandemic shutdowns, Nadezhda Petrusiva and her charity, Mercy, have been overwhelmed with pleas for help from single mothers with several hungry children, people with disabilities, and people who are simply terrified by the pandemic.
They call her center asking for food as early as 5 a.m. The center’s volunteers or, as they prefer to call themselves, “people of goodwill,” begin their mornings packing and delivering basic foods—parcels with cereal, flour, bread—for those in trouble. Grandmothers arrive with small pails to pick up their hot meals; homeless people eat at the center’s table.
More than 16 percent of the population in Smolensk lives in poverty, trying to survive on less than $5.50 a day. The coronavirus crisis made their situation even more desperate. The Kremlin’s head of the Accounting Chamber, Aleksey Kudrin, predicts that the number of unemployed in Russia as a whole will triple in the coming months.
“Never in my eight years of work in charity have I seen so many hungry and desperate people as during these months of coronavirus pandemic,” says Mercy’s Petrusiva.
Putin declared the economic shutdown in late March, after visiting Moscow’s new coronavirus hospital. That was the last time the nation saw the leader in action, dressed in full anti-plague gear, inspecting the so-called “red zone” full of patients with pneumonia. [19, 20]
Since then Putin’s key men, including the hospital chief doctor Denis Protsenko, Russian Prime Minister Mikhail Mishustin, and the presidential spokesman Dmitry Peskov have been diagnosed with coronavirus one after another.
BODY COUNTS
Russia’s official death toll has not been nearly as bad as in the United States, Italy, or the United Kingdom, for reasons that are still unclear. District clinics monitor every positive patient at home, possibly providing early care that reduces deaths, but experts say that not all statistics are fully transparent.
In April, Moscow’s COVID-19 death toll was 695 people, while the total number of deaths recorded that month was 1,800 higher than usual. “There are people who die from cancer, cardio-vascular disease, but the autopsy shows that they also had COVID-19; their names are not included in the statistics and that’s where, of course, politics appear here, when governors report to the president, to the federal authorities on the COVID-19 death toll,” Aleksey Venediktov, editor-in-chief of Echo of Moscow radio station, told listeners on Saturday. “There will be more dying," he said. “We are in the middle of the process.” [8]
Last Monday Russia saw a huge spike in infections—it is now second only to the United States in total numbers. And Russian authorities seem to have stumbled in protecting medical workers. Nobody, not even the most skillful propagandists, would be able to hide that fact. Due to sloppiness and disorganization, 190 Russian doctors and medics have died from COVID-19, according to a list called “We Remember” compiled by fellow physicians.
Last month, Putin promised $300 bonuses for medics working with coronavirus patients and $600 bonuses for doctors treating patients in so-called “red zones;” but when doctors received their salaries for April, the bonuses were missing. Russian medical workers, repeatedly called “heroes of our times” by state television, are calling for Putin to pay them the promised bonuses. So far 106,762 people have signed their petition.
OPPOSITION OPPORTUNITY
Putin’s opponents on both left and right are using this shaky pandemic moment to try to rock Putin’s world. “The power is in agony, their authority is running through their fingers,” says a young communist parliament member, Nikolai Bondarenko.
Liberal opposition leader Aleksey Navalny is pressuring the Kremlin online to help poor Russians to stock their empty refrigerators with concrete financial aid in his “Five steps for Russia” program.
Might the Kremlin put more pressure on the independent press and the opposition to shut down critics and help Putin’s approval rating? Probably not.
“Authorities cannot afford to tighten more bolts now, people already are gritting their teeth,” the founder of Transparency International’s Russian office, Yelena Panfilova, told The Daily Beast. “They might whip a few ministers for a show and maybe put a bit more pressure on the media—they need to look nice for the public.” That’s getting harder and harder for the Putin regime to do. [21, 22]
At least 25 million people in China are under enhanced coronavirus lockdowns after an outbreak of 34 cases in a province next to Russia
China has reimposed lockdown measures on northeastern provinces after clusters of new coronavirus cases emerged.
The most recent 34 cases were in the province of Jilin, where its two main cities of Shulan and Jilin City have both been placed under renewed lockdown, according to Channel News Asia. There are strict controls on transport and public gatherings, and schools have had to re-close, the channel reported. [10]
Another three cases have been found in the neighboring province of Liaoning, according to the channel. Jilin borders North Korea and Russia, the latter being one of the worst-affected countries in the world. [17, 18]
With the borders are sealed to foreigners, officials suspect that the new outbreak can be traced back to Chinese nationals returning from Russia, according to Bloomberg.
Shulan's government announced the lockdown measures over WeChat on Monday, sealing off residential compounds with suspected or confirmed cases.
Under this lockdown, one resident from a single family may only leave once for two hours every two days for essential supplies.
The sale of anti-fever medicines has also been banned across the province to prevent people from attempting to conceal their symptoms, according to Bloomberg. Delivery services have also mostly halted, the outlet reported.
In neighboring Liaoning, the 8.3 million people in the capital Shenyang are also facing renewed restrictions after three new cases were found on May 11, Channel News Asia said.
The reopening of schools has been delayed and 7,500 residents are under quarantine, according to the channel.
The outbreaks in Jilin and Liaoning come nearly a month after a city in another neighboring province, Heilongjiang, saw a spate of 386 new cases.
On April 26, the province's government imposed lockdown measures in the nearly 1 million-strong city of Mudanjiang, which borders Russia, according to Deutsche Welle. In Harbin, the provincial capital, the measures are lighter but local residents are only allowed to move within their own neighborhoods, reported the newspaper.
New cases of the virus in China have not exceeded 100 per day since mid-April. According to Bloomberg, Jilin province has reported no more than 127 since the coronavirus first began to spread.
The Chinese government is poised to begin its postponed "Two Sessions" political meetings, and was set to relax its borders soon after, according to the Guardian. [23, 24]
Vice Premier Sun Chunlan, a high-ranking Communist Party official, arrived in Jilin on May 13, according to Bloomberg. The next day, a 12-strong team of medics was sent from the neighboring Liaoning Province, who previously worked in heavily-affected Hubei Province, according to state media outlet The Global Times.
"Medical treatment for the confirmed patients in the city is going well, with everything under control," Liu Qi, who leads the team, told the outlet.
Mass testing is currently underway in former coronavirus epicenter Wuhan after six new cases were found. But Wang Peiyu, a deputy head of Peking University's School of Public Health, told The Global Times this is not necessary in Jilin.
Chinese streaming firm iQIYI saw its first quarter losses increase to $406 million (RMB2.88 billion), while revenues and subscriptions improved.
The NASDAQ-listed company reported 119 million paying subscribers, a year-on year increase of 23%. That implies growth of 12 million subscribers in the January to end of March period in which much of China was in stay-at-home or lockdown mode due to the coronavirus outbreak. [25, 26]
With average spending per user also increasing, the subs spurt lifted subscription revenues by 35% in the quarter. Games and content sales revenues also increased. But advertising revenues plunged 27% to $217 million, and other revenues were also down. Overall group revenues managed a 9% increase to $1.1 billion (RMB7.6 billion).
Gong Yu, founder and CEO said: “We delivered solid results during the first quarter despite very challenging environment caused by the COVID-19 outbreak.” Net losses in the equivalent quarter last year were RMB1.81 billion. Losses in the fourth quarter of 2019 were RMB2.50 billion. [27, 28, 29]
In its guidance for the second quarter of 2020, iQIYI said it expects total net revenues to be between RMB7.25 billion (US$1.02 billion) and RMB7.67 billion (US$1.08 billion), representing a 2% to 8% increase from the same period in 2019.”
Cash on hand at the end of March was down to $1.4 billion. That compared with $1.7 billion at the end of December.
The company’s content costs increased by 11% to $836 million in the first quarter. For the near future, the company threw out a crumb of comfort as the effects of the coronavirus outbreak begin to diminish. “With content production back up and running since late March, iQIYI is gradually recovering toward the normal level, and short-term uncertainties on future pipeline caused by the pandemic is fading away, and the content pipeline for the second quarter is very strong.” Content highlights in the January-March period included the fifth and final season of “iPARTMENT,” viewed by over 170 million users by the time its finale was aired, and girl group talent show “Youth With You Season 2,” where K-pop star Lisa from Blackpink was one of the mentors. (30, 31)
China protests at support of U.S. and others for Taiwan at WHO
The Chinese envoy to the World Health Organization (WHO) on Tuesday denounced the support shown by the United States and others to Taiwan during its annual ministerial assembly and said that was undermining the global response to the pandemic.
Taiwan lobbied hard to be included as an observer at the two-day virtual meeting and received strong support from the United States, Japan and others, but says it was not invited due to opposition from China. [32, 33]
"There are still a few countries determined to plead for Taiwan authorities, seriously violating relevant U.N. and WHO resolutions and undermining global anti-epidemic efforts," Chen Xu, the Chinese ambassador, told the virtual assembly.
"China solemnly protests and firmly opposes this behaviour."
Taiwan is locked out of U.N. organisations such as the WHO due to the objections of China, which considers it a breakaway province with no right to the trappings of a sovereign state.
The WHO says it is bound by U.N. protocol, and that Taiwan can only be included in WHO meetings if the members make a decision to do so. [34]
Several delegates protested at Taiwan's exclusion in their speeches, including senior U.S. diplomat Howard Solomon in closing remarks as well as Haiti and Paraguay.
Shortly after the U.S. speech, Chen dismissed the remarks as "political hype", saying: "This conduct is not acceptable."
Taiwan's president, Tsai Ing-wen, is due to say on Wednesday that the island will continue to strive to participate actively in global bodies despite the setback at the WHO.
India has launched a full-scale investigation against China’s Wuhan Institute of Virology. The Indian government has ordered an inquiry into a study conducted in the Northeastern state of Nagaland (close to China) by researchers from the U.S., China and India on bats and humans carrying antibodies to deadly viruses like Ebola.
We must have an investigation of the outbreak in Wuhan. The Chinese must grant the world total transparency. The truth must come out. If Chinese officials are innocent, they have nothing to hide. If they are guilty, they will refuse to cooperate.
The real concern here is whether the rest of the world has the courage to demand a real and thorough investigation. We need to be fearless in this demand and not allow “economic interests” to play a coy and dishonest game of denial. We need an honest inquiry. We need it now.
The corrupt establishment will do anything to suppress critical sites like the Burning Platform, etc., from revealing the truth. The corporate media does this by demonetizing sites like mine by blackballing the site from advertising revenue.
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
